Japan vs Latvia: Hepatitis B surface antigen (HBsAg) prevalence
Japan
0.0%
in 2024
Latvia
0.0%
in 2024
Japan rank
132nd
Latvia rank
132nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Japan
- Latvia
How they compare
Japan currently reports 0.0% against 0.0% in Latvia, a difference of 0.0%.
Across all 10 years both countries report, Latvia has been ahead every year.
Japan ranks 132nd and Latvia ranks 132nd of 194 countries.
Latvia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Japan | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.1% | 0.0% | Latvia |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Japan or Latvia?
- Japan, at 0.0% against 0.0% in Latvia as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Japan and Latvia?
- 0.0%, with Japan ahead.
- How many years of comparable data are there for Japan and Latvia?
- 10 years are reported by both, from 2015 to 2024.
- How do Japan and Latvia rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Japan ranks 132nd and Latvia ranks 132nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.